← Open Payments lookup

BRIAN SCHLESINGER: Open Payments

NPI 1013018944 · PALMDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$625 in 24 payments from 10 companies in 2025. Trend: 2023 $396 · 2024 $577 · 2025 $625

Food & beverage: $625
CompanyPaymentsAmount
Boehringer Ingelheim Pharmaceuticals, Inc.13$349
ABBVIE INC.2$48
AstraZeneca Pharmaceuticals LP2$48
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$34
Lilly USA, LLC1$30
SANOFI-AVENTIS U.S. LLC1$26
Otsuka America Pharmaceutical, Inc.1$24
Novo Nordisk Inc1$23
ALK-Abello, Inc1$23
GlaxoSmithKline, LLC.1$21

Products named: JARDIANCE, VRAYLAR, CAPLYTA, MOUNJARO, BREZTRI, TZIELD, REXULTI, Odactra.

Industry payments across CA — which companies pay providers there.